Research

Scientists at the OSU Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute and throughout the country continue to conduct cutting-edge research on  lymphoma in the hopes of finding a cure for thousands of individuals who are diagnosed with the disease each year. The Lymphoma Research Foundation has called lymphoma the “Rosetta Stone” of cancer research because “it has helped unlock the mysteries of several other types of cancer.”

Already scientists have broken ground on potentially promising advances in the areas of several treatments, including:

  • New antibody treatments that target specific antigens on the lymphoma cells;
  • Vaccines that prompt the body’s immune system to attack the lymphoma;
  • Tumor profiling, which involves examining tumor gene patterns to help in prognosis and new therapies; and
  • New biologic therapies that target unusual abnormalities specific to certain lymphomas.

See the following Web sites for more information on lymphoma research:

OSU James Cancer Hospital 
information on the James Cancer Hospital’s most recent cancer research.

Cutaneous Lymphoma Foundation
An independent, non-profit patient advocacy organization, the Cutaneous Lymphoma Foundation provides information on diagnosis, treatment and research for patients diagnosed with mycosis fungoides, Sezary syndrome and other forms of cutaneous T-cell lymphomas.

Lymphoma Research Foundation 
The Lymphoma Research Foundation (LRF) is the nation’s largest lymphoma-focused voluntary health organization devoted exclusively to funding lymphoma research and providing patients and healthcare professionals with information.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 460 W. 10th Avenue, Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu